These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19433749)

  • 21. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
    Rouwette M; Somers K; Govarts C; De Deyn PP; Hupperts R; Van Wijmeersch B; De Jong BA; Verbeek MM; Van Pesch V; Sindic C; Villar LM; Álvarez-Cermeño JC; Stinissen P; Somers V
    J Neurochem; 2012 Nov; 123(4):568-77. PubMed ID: 22958230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes.
    Jolivet-Reynaud C; Perron H; Ferrante P; Becquart L; Dalbon P; Mandrand B
    Clin Immunol; 1999 Dec; 93(3):283-93. PubMed ID: 10600340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.
    Karnezis T; Mandemakers W; McQualter JL; Zheng B; Ho PP; Jordan KA; Murray BM; Barres B; Tessier-Lavigne M; Bernard CC
    Nat Neurosci; 2004 Jul; 7(7):736-44. PubMed ID: 15184901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens.
    Hauben E; Ibarra A; Mizrahi T; Barouch R; Agranov E; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15173-8. PubMed ID: 11752461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF examination still has value in the diagnosis of MS - Commentary.
    Arrambide G; Tintore M
    Mult Scler; 2016 Jul; 22(8):997-8. PubMed ID: 27059063
    [No Abstract]   [Full Text] [Related]  

  • 26. CSF examination still has value in the diagnosis of MS-YES.
    Brundin L
    Mult Scler; 2016 Jul; 22(8):994-5. PubMed ID: 27059061
    [No Abstract]   [Full Text] [Related]  

  • 27. CSF examination still has value in the diagnosis of MS - NO.
    Killestein J; Uitdehaag BM
    Mult Scler; 2016 Jul; 22(8):995-7. PubMed ID: 27059062
    [No Abstract]   [Full Text] [Related]  

  • 28. Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination.
    Cohen SR; Herndon RM; McKhann GM
    Trans Am Neurol Assoc; 1976; 101():45-7. PubMed ID: 1028269
    [No Abstract]   [Full Text] [Related]  

  • 29. Nogo in multiple sclerosis: growing roles of a growth inhibitor.
    Fontoura P; Steinman L
    J Neurol Sci; 2006 Jun; 245(1-2):201-10. PubMed ID: 16682057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
    Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J
    J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
    Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
    J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges to the report of Nogo antibody effects in primates.
    Tuszynski M
    Nat Med; 2006 Nov; 12(11):1231-2; author reply 1232-3. PubMed ID: 17088880
    [No Abstract]   [Full Text] [Related]  

  • 34. Challenges to the report of Nogo antibody effects in primates.
    Ho C; Tessier-Lavigne M
    Nat Med; 2006 Nov; 12(11):1232; author reply 1232-3. PubMed ID: 17088884
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to myelin basic protein in multiple sclerosis.
    Hughes RA; Gray I; Clifford-Jones R; Stern M
    Proc R Soc Med; 1977 Dec; 70(12):874-6. PubMed ID: 601066
    [No Abstract]   [Full Text] [Related]  

  • 36. Cleavage of cystatin C is not associated with multiple sclerosis.
    Del Boccio P; Pieragostino D; Lugaresi A; Di Ioia M; Pavone B; Travaglini D; D'Aguanno S; Bernardini S; Sacchetta P; Federici G; Di Ilio C; Gambi D; Urbani A
    Ann Neurol; 2007 Aug; 62(2):201-4; discussion 205. PubMed ID: 17006926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunolocalization of proteolipid protein peptide 103-116 in myelin.
    Sobel RA; Greer JM; Isaac J; Fondren G; Lees MB
    J Neurosci Res; 1994 Jan; 37(1):36-43. PubMed ID: 7511704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Bednárová J; Stourac P; Adam P
    Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimyelin basic protein antibodies and cellular hypersensitivity in multiple sclerosis.
    Sheremata W; Wood DD; Moscarello MA
    Trans Am Neurol Assoc; 1976; 101():291-4. PubMed ID: 1028264
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-myelin antibodies in multiple sclerosis: clinically useful?
    Polman CH; Killestein J
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):712. PubMed ID: 16705192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.